Clinical Trials Directory

Trials / Unknown

UnknownNCT01315262

On Demand Versus Daily Sildenafil for Patients Undergoing Radical Prostatectomy

On Demand Versus Daily Sildenafil for Patients Undergoing Bilateral Nerve Sparing Radical Prostatectomy: a Randomized, Open Label, Parallel Group Trial

Status
Unknown
Phase
Phase 3
Study type
Interventional
Enrollment
200 (estimated)
Sponsor
Università Vita-Salute San Raffaele · Academic / Other
Sex
Male
Age
18 Years – 65 Years
Healthy volunteers
Not accepted

Summary

Viagra (Sildenafil citrate) is an orally active selective inhibitor of cyclic guanosine monophosphate (cGMP)-specific phosphodiesterase type 5 (PDE5) which is used for the treatment of erectile dysfunction (ED). Objectives: * To test the efficacy of Viagra 100mg on demand vs. Viagra 100mg daily (taken either at bedtime or 1 hour prior to sexual intercourse) in restoring erectile function following radical prostatectomy. * To test the safety and tolerability of Viagra 100 mg on demand vs. Viagra 100 mg daily after radical prostatectomy.

Conditions

Interventions

TypeNameDescription
DRUGSildenafil1:1 Viagra 100 mg daily (taken either at bedtime - if sexual intercourse is not expected - or 1 hour prior to sexual intercourse, no more than one 100 mg dose of sildenafil per day) vs. Viagra 100mg OD (i.e. one hour prior to sexual intercourse)

Timeline

Start date
2011-01-01
Primary completion
2012-09-01
Completion
2012-12-01
First posted
2011-03-15
Last updated
2011-03-29

Locations

1 site across 1 country: Italy

Source: ClinicalTrials.gov record NCT01315262. Inclusion in this directory is not an endorsement.